Three transcription factors, Sox2, Oct-3/4 and Nanog, have been identified as master regulators that orchestrate mammalian embryogenesis as well as the self-renewal and pluripotency of ES (embryonic stem) cells. Efforts to understand how these transcription factors function have shown that they have a special property in common. Small changes in the expression of any one of these factors dramatically alter the self-renewal and pluripotency of ES cells. In this way, each functions as a molecular rheostat to control the behaviour of ES cells. Recent studies have begun to examine the molecular mechanisms that regulate the levels of these transcription factors. In this issue of the Biochemical Journal, Mullin and co-workers report that Nanog can self-associate to form dimers. Importantly, they also show that the domain responsible for dimerization is also needed for Nanog to sustain the self-renewal of ES cells in the absence of the cytokine LIF (leukaemia inhibitory factor). On the basis of their studies, they propose a novel mechanism for regulating the interactions between Nanog and other nuclear proteins.
As the list of genes found to be essential for mammalian embryogenesis continues to grow, three transcription factor genes, Nanog, Sox2 and Oct-3/4 (also known as Oct4 and Pou5f1), have taken centre stage. By many criteria, Sox2, Oct-3/4 and Nanog behave as master regulators. Each is essential for mammalian embryogenesis and each exerts a powerful effect on the selfrenewal and pluripotency of ES (embryonic stem) cells (reviewed in [1] ). Given their critical roles during embryogenesis, it is not surprising that these transcription factors strongly influence their own expression, both positively and negatively, at the transcriptional level [2] . Remarkably, ChIP-on-chip studies have determined that Sox2, Oct-3/4 and Nanog co-occupy over 300 genes in human ES cells, approximately half of which are expressed in these cells [3] . Although Nanog binds to many of these genes, it is unclear whether Nanog co-operates with Sox2 and Oct-3/4 in their regulation. In fact, most evidence suggests that Nanog exerts its critical roles during development by regulating different sets of target genes that make up other essential gene regulatory networks.
The master regulators Nanog, Sox2 and Oct-3/4 have a special property in common. Each functions as a molecular rheostat in their regulation of the self-renewal and pluripotency of ES cells. In 2000, Niwa et al. [4] made the exciting discovery that increases or decreases in Oct-3/4 protein (as small as 50 %) are sufficient to promote and direct the differentiation of ES cells. Given that the Oct-3/4 gene appears to be strongly regulated by a positive feedback loop involving the combined action of Sox2 and Oct-3/4 itself [5] , it was to be expected that mechanisms would exist to limit Oct-3/4 expression. Efforts to understand how the Oct-3/4 gene is controlled led to the finding that small increases in the levels of either Sox2 or Oct-3/4 are sufficient to inhibit the activity of the Oct-3/4 promoter [2] . Unexpectedly, overexpression of Sox2 in ES cells was found to exert an overarching inhibitory effect on the promoters of at least five Sox2:Oct-3/4 target genes, including promoters of the Oct-3/4, Sox2, Nanog, FGF-4 and UTF1 genes [2] . This surprising finding led directly to the prediction that small increases in the levels of Sox2 would promote the differentiation of ES cells. Although knockdown of Sox2 had been shown to promote the differentiation of ES cells into trophectoderm-like cells, there were conflicting reports concerning the effects of overexpressing Sox2 in ES cells. This conflict was resolved using Sox2-inducible ES cells. With this model system, it was shown recently that small increases in Sox2 protein (2-fold or less) trigger the differentiation of ES cells into a wide range of differentiated cell types, including neuroectoderm, mesoderm and trophectoderm, but not endoderm [6] . Thus, like Oct-3/4, Sox2 behaves as a bona fide molecular rheostat that influences the self-renewal and pluripotency of ES cells.
The levels of Nanog have also been shown to influence the tendency of ES cells to differentiate [7] [8] [9] . Studies in the early 1980s had shown that mouse ES cells could be maintained in an undifferentiated pluripotent stem cell state by culturing them on a growth-inactivated feeder layer or in the presence of the cytokine LIF (leukaemia inhibitory factor). Efforts to understand the action of LIF eventually led to the discovery that elevating the levels of Nanog could prevent the differentiation of ES cells when LIF is removed from the culture medium [8, 9] . Although these early studies had shown that Nanog null ES cells exhibit a propensity to differentiate into extraembryonic endoderm-like cells [8] , subsequent studies determined that Nanog null ES cells could be maintained in culture [7] . Importantly, work with Nanog has shown that one of its important roles during development is in the formation of germ cells [7] . However, this is unlikely to be the sole role of Nanog, given the demise of Nanog null mouse embryos around the fourth to fifth day of gestation [8] .
It is evident that small changes in master regulators, such as Nanog, strongly influence the behaviour of ES cells. This is not surprising, given that master regulators behave as high nodes in critical gene regulatory networks that influence large groups of genes. To date, the cellular pathways impacted by changes in the expression of Sox2, Oct-3/4 and Nanog remain largely e6 A. Rizzino unknown. However, this fundamental gap in our knowledge is beginning to be addressed, especially in the case of Nanog. Recent proteomic studies have identified a large list of transcription factors that interact, either directly or indirectly, with Nanog, including Sall4, Sall1, Rif1, Tif1, Dax1, Zfp281, Oct4 and Nac1 [10, 11] . Importantly, these findings have already provided new insights into the regulation of genes that play key roles during development. For example, these findings led to the discovery that Nanog and Sall4 bind in close proximity to one another in the putative regulatory regions of their own genes [10] . This suggests that these two essential transcription factors cooperatively regulate their own expression by a positive feedback loop, similar to the one used by Sox2 and Oct-3/4 to regulate their own expression [2, 5, 12] . If this proves to be the case, one might also expect to find a negative feedback loop that limits the transcription of both the Nanog gene and the Sall4 gene, as well as that of their primary target genes. In the case of Nanog, evidence already exists that its overexpression limits the activity of the Nanog promoter [2] . Proteomic analyses also led directly to the finding that Nanog, Nac1 and Zfp281 can each bind to the GATA6 promoter, where it appears that they repress GATA6 transcription and prevent its expression until ES cells differentiate into endoderm [11] . Perhaps most importantly of all, Dax1, Nac1, Zfp281 and Oct4, like Nanog, have each been found in large protein complexes, which range in size up to several megadaltons [11] . Given that many of these proteins are found associated with one another in a wide distribution of multiprotein complexes, it is possible, if not likely, that these transcription factors work together co-operatively to provide combinatorial control over large sets of critical genes. Thus small increases or small decreases in one or more of these critical transcription factors would be expected to disrupt the overall stoichiometry and complexity of the multiprotein complexes required to maintain the self-renewal and/or pluripotency of ES cells. As attractive and straightforward as this model may be for a molecular rheostat, recent studies argue that there is far more to be learned about the mechanisms that regulate the formation of Nanog multiprotein complexes.
In this issue of the Biochemical Journal, Mullin et al. [13] report that Nanog (305 amino acids) can self-associate and form dimers. Working with rNanog (recombinant Nanog), which required an on-column refolding protocol, these workers determined from sedimentation velocity measurements that rNanog can exist as a dimer. Moreover, using size-exclusion chromatography, they determined that rNanog can also form large complexes that migrate with sizes well in excess of 200 kDa. On the basis of their findings, Mullin and co-workers argue that the broad range in the sizes of endogenous Nanog complexes present in extracts isolated from ES cells may not be solely due to the interaction of Nanog with other nuclear proteins. This argument is supported by their discovery that the WR (tryptophan-rich) domain of Nanog, which is located in the C-terminal half of the protein (residues 198-243), is primarily responsible for Nanog self-association. In agreement with earlier studies, Mullin et al. [13] show, using size-exclusion chromatography, that Nanog expressed by ES cells migrates in a wide range of protein complexes, many of which are much larger than 200 kDa. In strong contrast, expression of a mutant form of Nanog in ES cells, in which only the WR domain of Nanog has been deleted (Nanog WR), gives rise to Nanog that migrates predominantly as a monomer. If this surprising finding is not due to the misfolding of Nanog WR, which seems unlikely, it raises the intriguing possibility that the WR domain functions as a regulatory switch to selectively control which nuclear proteins interact with Nanog. For example, monomeric and dimeric forms of Nanog may each interact with different groups of nuclear proteins [13] . Although less likely, the dimerization of Nanog may simply restrict its ability to interact with other nuclear proteins altogether. In either case, controlling Nanog dimerization, by the availability of appropriate partner proteins, and/or by post-translational modification, could provide an important mechanism by which the levels of this molecular rheostat are regulated precisely.
The study by Mullin et al. [13] is remarkable for another reason. Previous studies had reported that the C-terminal tail of Nanog (the CD2 domain; residues 248-305) is required for Nanog, when overexpressed in ES cells, to replace the requirement for LIF [14] . However, Mullin et al. [13] report that deleting the last 49 amino acids of Nanog (virtually the entire CD2 domain) has little effect on the ability of Nanog C49-engineered ES cells to generate colonies of morphologically undifferentiated cells when LIF is removed from these cultures. Moreover, Mullin and co-workers report that ES cells expressing elevated Nanog WR are unable to self-renew and form morphologically undifferentiated cells when LIF is removed. There are several possible explanations for the radically different results reported in these two studies [13, 14] , including differences in the ES cells used, culture conditions employed, levels of Nanog expression and/or other differences in experimental design. Hopefully, this important issue will be resolved in the not-too-distant future.
In summary, although it is becoming increasingly clear that key transcription factors, such as Sox2, Oct-3/4 and Nanog, behave as master regulators during development, the molecular mechanisms that enable them to function as molecular rheostats are poorly understood. Efforts under way in many laboratories offer the hope that we will soon gain a far better understanding of the mechanisms involved. Towards this goal, Mullin et al. [13] propose a novel mechanism for regulating the interactions between Nanog and other nuclear proteins. Finally, given our evolving view of molecular rheostats, we should bear in mind that small increases may be just as likely as small decreases in the expression of master regulators to direct cell fate decisions during development.
